Mark Mullikin | Vice President, Finance and Investor Relations |
Cindy Collins | Chief Executive Officer |
Charles Albright | Chief Scientific Officer |
Michelle Robertson | Chief Financial Officer |
Peter Kim | Barclays |
Max Skor | Morgan Stanley |
Phil Nadeau | Cowen & Company |
Steve Seedhouse | Raymond James |
Yanan Zhu | Wells Fargo Securities |
Joon Lee | Truist Securities |
Jay Olson | Oppenheimer |
Good afternoon and welcome to Editas Medicine Second Quarter 2020 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised, that this call is being recorded at the company’s request. I would now like to turn the call over to Mark Mullikin, Vice President of Finance and Investor Relations at Editas Medicine.